PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway

Background: Proline-, glutamic acid-, and leucine-rich protein 1 (PELP1), a co-activator of estrogen receptors alpha, was confirmed to be directly associated with the oncogenic process of multiple cancers, especially hormone-dependent cancers. The purpose of our research was to explore the biologica...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Yan, Hongzhu, Sun, Yanling, Wu, Qian, Wu, Zhe, Hu, Meichun, Sun, Yuanpeng, Liu, Yusi, Ma, Zi, Liu, Shangqin, Xiao, Wuhan, Liu, Fuxing, Ning, Zhifeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7031343/
https://ncbi.nlm.nih.gov/pubmed/32117782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01423
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller